OpenAI joins $30m funding for biotech AI startup Valthos. Valthos, a biotech startup, has secured US$30 million in funding from the OpenAI Startup Fund, Lux Capital, and Founders Fund. The company develops AI-powered tools for government and life sciences organizations to help identify and respond to biological threats. Valthos said its technology aims to speed up the detection and mitigation of risks posed by advances in biotechnology. The founding team includes former employees from Palantir, DeepMind, the Broad Institute, and the Arc Institute. The startup is currently hiring to expand its operations. Food for thought. DoD compliance takes more than slogans. * Valthos says it serves government and life sciences customers yet cites no federal procurements, pilots, or partnerships that prove use in biodefense. * For Department of Defense (DoD) projects with Controlled Unclassified Information (CUI) or National Security Systems (NSS), cloud services must hold Impact Level 5 (IL5) authorization 1. The Defense Information Systems Agency (DISA) evaluates providers, then issues a provisional authorization aligned to Federal Risk and Authorization Management Program (FedRAMP) High baselines 1. * DoD agencies cannot run CUI or NSS workloads on a vendor platform unless the environment is IL5 authorized and built on a FedRAMP High baseline 1. Access must be limited to US citizens, US nationals, or US persons within IL5 locations with separation rules 1. * Press releases do not equal contracts. Check DoD procurement records and Small Business Innovation Research (SBIR) awards to see if agencies are piloting or buying Valthos' tools. Cloud providers can win biodefense AI demand. * Government use of biodefense AI will lift demand for GPU infrastructure that meets DoD IL5 rules 1. Azure Government is Microsoft's US government cloud and offers IL5 GPU compute in US Gov Arizona, Texas, and Virginia 1. * Vendors without IL5 GPU services face a gap 1. Integrating NVIDIA H100 class compute within FedRAMP High based IL5 environments opens deals 1. * Parallel Works, a platform for orchestrating high-performance computing (HPC) workflows, secured DoD IL5 authorization in August 2025 for hybrid multi-cloud HPC management for defense contractors and national labs 2. * System integrators, IT services firms that assemble and secure complex systems, can build pipelines that link IL5 cloud environments to Defense Supercomputing Resource Centers 2. These pipelines ease the bottleneck between biodefense AI development and authorized deployment infrastructure 2. How would you feel if you could no longer use Tech in Asia?

OpenAI-Backed Valthos raises $30 million to combat ai-enabled biological threats. Valthos said Friday (Oct. 24) that it has raised $30 million to build "next-generation biodefense" to combat the threat of biological threats enabled by artificial intelligence. This kind of defense is needed because AI has expanded access to biotechnologies that can create diseases as well as eliminate them, the company said in a Friday blog post. "Today, it's faster to weaponize biology than to advance new cures," Valthos said in its post. "Leaders in AI have identified this as one of the largest threats of our time." Valthos is building tools that government and life sciences experts can use to identify biological threats and design medical countermeasures to respond to them, according to the company's website. "We build AI systems to rapidly characterize biological sequences and update medicines in real time," the company said in the post. "This strengthens biodefense today and lays the groundwork for the adaptive, precision therapeutics of tomorrow." Valthos Co-founder and CEO Kathleen McMahon wrote in a Friday post on X: "We have an opportunity to use emerging AI methods to strengthen biodefense - earlier detection of threats, faster, more precise medicine. It's a race to get these systems in place to deter the worst case and we're running out of time. This is the problem I want to solve." McMahon added in another Friday post that Valthos will bring expertise in operational software and machine language to experts who are on the frontline of biodefense. Valthos said in its blog post that its investors include the OpenAI Startup Fund, Lux Capital and Founders Fund. Lux Capital Partner Grace Isford wrote in a Friday post on X: "Thrilled to unveil [Lux Capital] incubation [Valthos] - they're building next-generation biodefense powered by AI." Isford added in the post that McMahon built and led Palantir's life sciences business. PYMNTS reported in October 2024 that AI is transforming pharmaceutical research, compressing timelines and potentially slashing drug prices. A 2024 report sponsored by the State Department revealed national security threats due to fast-developing artificial intelligence and highlighted the urgent need for federal action to prevent a crisis, PYMNTS reported at the time.